abstract |
The present invention relates to a composition comprising an angiogenesis inhibitor that binds to a therapeutic or diagnostic substance. In a specific embodiment, the composition is a fusion gene or fusion gene product encoding an angiogenesis inhibitor that binds to a therapeutic or diagnostic agent. In certain embodiments, the composition is used as a method of treating angiogenesis-related diseases such as cancer. |